A nationwide class action lawsuit alleges Costco's Kirkland Signature Rotisserie Chicken is misleadingly marketed as having 'No Preservatives,' spotlighting growing scrutiny over clean-label claims in the grocery sector and potential risks to the retailer's reputation.
Brazil's state-controlled oil giant Petrobras is trading at deep value multiples, offering investors a covered dividend yield near 10%. Analysts argue its disciplined payout and exposure to a tightening global oil market create a rare mix of income and asymmetric upside.
As DoorDash trades near $205, analysts debate whether its integrated logistics platform, likened to a modern utility, justifies its premium multiples amid expansion into groceries and international markets.
Shares of Huntington Bancshares (HBAN) have climbed over 17% in the past 90 days, closing recently at $17.88. This rally has investors scrutinizing whether the regional bank's stock still holds value after its strong run, with some models suggesting a significant upside to fair value.
National average gasoline prices showed minimal movement in the week ending February 2, 2026, hovering near $2.88 per gallon. However, the gap between the most and least expensive markets exceeds $2.65, highlighting ongoing regional volatility despite overall price stability.
In a landmark interview, three of the youngest Turpin siblings detail their harrowing journey from their parents' infamous captivity to alleged abuse in foster care, revealing a system that failed them twice.
Capital Management Corp significantly boosted its stake in the logistics and mailing solutions provider, signaling confidence in its financial recovery and cash generation despite a revenue dip.
Arabica futures edge higher on technical moves, while robusta prices tumble as favorable weather in Brazil and surging Vietnamese exports point to ample supplies, pressuring the market.
Starbucks returns to Super Bowl weekend with a cinematic pre-game spot celebrating its role as Team USA's coffee partner, blending Italian film aesthetics with Olympic grandeur to drive its brand turnaround narrative.
Sportradar Group's (SRAD) shares have tumbled over 20% in the past month, pushing the sports data giant back into the spotlight. With a stark disconnect between its current price and some bullish fair value estimates, investors are debating whether this is a moment of weakness or a warning signal.
Devon Energy's shares have surged over 23% in the last 90 days, reigniting the debate over whether its current price accurately reflects the oil and gas producer's robust cash flows and long-term fundamentals.
Taiwan Semiconductor Manufacturing Company (TSMC), commanding over 70% of the advanced chip foundry market, is accelerating its U.S. manufacturing footprint amid shifting trade policies and sustained explosive financial growth, solidifying its indispensable role.
Despite a bearish crypto market, Ripple is advancing its real-world banking integrations through tokenization trials. While on-chain metrics show institutional adoption growing, XRP's price continues to struggle, testing investor patience.
Amid a mixed market backdrop, penny stocks are drawing renewed attention for their growth potential. We analyze three standout picks, led by financial services firm Siebert Financial, highlighting their financial health and strategic moves in a volatile landscape.
While long-term trends favor consumer internet companies, recent underperformance against the broader market highlights selective pressures. We analyze one stock facing headwinds and two positioned for resilience in the current climate.
With backing from tech giants and a $2.5 billion valuation, Austin-based startup webAI is pioneering a radical shift: moving AI processing from massive, energy-hungry data centers directly to personal devices, promising greater efficiency, privacy, and user control.
Chinese courts have executed four individuals convicted of running a multi-billion dollar scam and gambling network from Myanmar, responsible for multiple deaths. The move signals Beijing's escalating pressure on Southeast Asia's industrial-scale cybercrime hubs.
Cogent Biosciences secures a key FDA Breakthrough Therapy Designation for its bezuclastinib-sunitinib combination in advanced GIST, following promising Phase 3 data that showed a halving of disease progression risk.
President Trump's apparent endorsement of a weaker dollar is not mere rhetoric but a strategic pillar of his economic agenda, aimed at boosting US competitiveness and narrowing the trade deficit, with significant implications for global central banks and currency markets.
Takeda Pharmaceutical's (TSE:4502) recent share price rally has ignited a debate among investors. With the stock closing at ¥5,242, analysts are divided on its true worth, presenting a complex picture of fair value signals and future growth prospects.
